NeoPharm CO., LTD. (KOSDAQ:092730)

South Korea flag South Korea · Delayed Price · Currency is KRW
18,100
-260 (-1.42%)
May 20, 2026, 3:30 PM KST
Market Cap283.11B +39.1%
Revenue (ttm)132.18B +11.1%
Net Income27.82B +20.6%
EPS1,778.81 +20.6%
Shares Out15.64M
PE Ratio10.18
Forward PE8.74
Dividend750.00 (3.91%)
Ex-Dividend DateDec 29, 2025
Volume51,951
Average Volume74,584
Open18,600
Previous Close18,360
Day's Range17,730 - 18,610
52-Week Range13,080 - 22,650
Betan/a
RSI41.39
Earnings DateAug 13, 2026

About NeoPharm CO., LTD.

NeoPharm Co., Ltd. engages in the development, manufacture, and sale of cosmetics, medical, and health products. Its products include emulsified and functional skin care products for sensitive and dry skin, treatment of atopic dermatitis and psoriasis, and therapy for steroid side effects. The company was founded on July 1, 2000 and is headquartered in Daejeon, South Korea. [Read more]

Founded 2000
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 092730
Full Company Profile

Financial Performance

In 2025, NeoPharm CO., LTD.'s revenue was 132.18 billion, an increase of 11.07% compared to the previous year's 119.01 billion. Earnings were 27.82 billion, an increase of 20.63%.

Financial Statements